WW International (FRA:WW60) Debt-to-EBITDA : -30.67 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:WW60 WW International Inc FRA:WW60
22 GF Score
Price €12.13
! 3 Warning Signs
View Full Analysis

What is WW International Debt-to-EBITDA?

WW International FRA:WW60 +2.80% 22 Debt-to-EBITDA is -30.67 as of Mar. 2026. GuruFocus rates FRA:WW60 with a GF Score™ of 22/100. The stock has 3 warning signs investors should review. Among 476 Healthcare Providers & Services companies, WW International ranks better than 83.4% on this metric.

Debt-to-EBITDA measures a company's ability to pay off its debt.

WW International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was €24.2 Mil. WW International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was €380.8 Mil. WW International's annualized EBITDA for the quarter that ended in Mar. 2026 was €-13.2 Mil. WW International's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 was -30.67.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for WW International's Debt-to-EBITDA or its related term are showing as below:

FRA:WW60' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -7.47   Med: -7.47   Max: 0.38
Current: 0.38

During the past 3 years, the highest Debt-to-EBITDA Ratio of WW International was 0.38. The lowest was -7.47. And the median was -7.47.

FRA:WW60's Debt-to-EBITDA is ranked better than
83.4% of 476 companies
in the Healthcare Providers & Services industry
Industry Median: 2.21 vs FRA:WW60: 0.38

WW International  (FRA:WW60) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


WW International Debt-to-EBITDA Related Terms


WW International Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for WW International's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

WW International Debt-to-EBITDA Chart

WW International Annual Data
Trend Dec23 Dec24 Dec25
Debt-to-EBITDA
0.00 -7.47 N/A

WW International Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-EBITDA Get a 7-Day Free Trial 0.00 0.00 3.21 8.75 -30.67

FRA:WW60 vs JYNT, PARK, BTMD: Debt-to-EBITDA Comparison

For the Medical Care Facilities subindustry, WW International's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


WW International Debt-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, WW International's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where WW International's Debt-to-EBITDA falls into.


FRA:WW60
22GF Score
WW International Inc FRA:WW60
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

WW International Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

WW International's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1.076 + 399.125) / N/A
=N/A

WW International's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(24.212 + 380.776) / -13.204
=-30.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of -30.67 mean?
WW International (FRA:WW60) has a Debt-to-EBITDA of -30.67 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on WW International. According to the industry distribution chart, WW International ranks #79 out of 476 companies in the Healthcare Providers & Services industry, placing it in the top 16.6%.
Is WW International's Debt-to-EBITDA too high?
WW International's current Debt-to-EBITDA is -30.67. Based on the distribution chart, WW International ranks #79 out of 476 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, WW International has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does WW International's Debt-to-EBITDA compare to JYNT and PARK?
According to the Healthcare Providers & Services industry distribution chart, WW International ranks #79 out of 476 companies for Debt-to-EBITDA. This places WW International in the top 17% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.21, based on 476 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on WW International. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. WW International's current Debt-to-EBITDA is -30.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WW International stock overvalued right now?
WW International (FRA:WW60) has a current Debt-to-EBITDA of -30.67. The current Debt-to-EBITDA is -30.67. WW International's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For WW International (FRA:WW60), the current Debt-to-EBITDA is -30.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

WW International Business Description

Other Exchanges WW:USA
Address 18 West 18th Street, 7th Floor, New York, NY, USA, 10011
WW International Inc specializes in weight management and providing clinical solutions in the United States. it also operates its proprietary digital platform that provides members with access to science-backed behavioral weight loss and weight management programs. The company's primary sources of revenue are subscriptions for digital, workshop, and clinical offerings. The Digital business refers to providing subscriptions to digital product offerings. Workshops + Digital business provides subscriptions for unlimited access to workshops combined with digital subscription product offerings. The Clinical business provides subscriptions to clinical product offerings combined with digital subscription product offerings and unlimited access to workshops.
22GF Score

Get the complete analysis for FRA:WW60

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.13
Price